Nimotuzumab in Adults With Glioblastoma Multiforma
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Determination of efficiency of nimotuzumab in adults with glioblastoma multiforma
Phase:
Phase 3
Details
Lead Sponsor:
Oncoscience AG
Collaborators:
Dep. of Neurosurgery and Policlinic, University Hospital, Dresden, Germany Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany Heinrich-Heine University, Duesseldorf Johann Wolfgang Goethe University Hospital Neurological Clinic of the University of Tübingen, Tübingen, Germany Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany Universität Tübingen Universitätsklinikum Hamburg-Eppendorf University of Bonn University of Giessen University of Kiel